Interleukin polymorphisms associated with overall survival, disease‐free survival, and recurrence in non‐small cell lung cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|54|S1|E172-E184

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.54, Iss.S1, 2015-06, pp. : E172-E184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Basic fibroblast growth factor shows prognostic impact on survival in operable non‐small cell lung cancer patients

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 450-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non‐small cell lung cancer

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E72-E80

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival analysis of patients with advanced non‐small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi‐center retrospective study

By  

Thoracic Cancer, Vol. 9, Iss. 2, 2018-02 ,pp. : 278-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self‐reported depression among patients with non‐small cell lung cancer

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 334-337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association between plasma fibrinogen and survival in patients with small‐cell lung carcinoma

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 146-151

John Wiley & Sons Inc

Access to resources Recommend Favorite